Nobuo Yoshimoto

1.7k total citations
74 papers, 1.3k citations indexed

About

Nobuo Yoshimoto is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nobuo Yoshimoto has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nobuo Yoshimoto's work include Cardiac Imaging and Diagnostics (16 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Nobuo Yoshimoto is often cited by papers focused on Cardiac Imaging and Diagnostics (16 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Nobuo Yoshimoto collaborates with scholars based in Japan, South Korea and United States. Nobuo Yoshimoto's co-authors include Shun’ichi Kuroda, Satoru Murao, Yasumi Uchida, Masumi Iijima, Tomoaki Niimi, Katsuyuki Tanizawa, Toru Kato, Kenji Tatematsu, Andrés D. Maturana and Gerd Heusch and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Nobuo Yoshimoto

73 papers receiving 1.2k citations

Peers

Nobuo Yoshimoto
Amanda Versteilen Netherlands
Begoña Lavín United Kingdom
Juichiro Shimizu Japan
Cesare Balduini Italy
H Nakazawa Japan
S. Nees Germany
Bernhard J. Kirschbaum Germany
J L Salzmann France
Carlos Tarín Spain
Aiilyan K. Houng United States
Amanda Versteilen Netherlands
Nobuo Yoshimoto
Citations per year, relative to Nobuo Yoshimoto Nobuo Yoshimoto (= 1×) peers Amanda Versteilen

Countries citing papers authored by Nobuo Yoshimoto

Since Specialization
Citations

This map shows the geographic impact of Nobuo Yoshimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Yoshimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Yoshimoto more than expected).

Fields of papers citing papers by Nobuo Yoshimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Yoshimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Yoshimoto. The network helps show where Nobuo Yoshimoto may publish in the future.

Co-authorship network of co-authors of Nobuo Yoshimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Yoshimoto. A scholar is included among the top collaborators of Nobuo Yoshimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Yoshimoto. Nobuo Yoshimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ito, Jumpei, Masumi Iijima, Nobuo Yoshimoto, et al.. (2015). Scaffold protein enigma homolog activates CREB whereas a short splice variant prevents CREB activation in cardiomyocytes. Cellular Signalling. 27(12). 2425–2433. 13 indexed citations
3.
Miyata, Takeshi, Masayuki Tadano, Nobuo Yoshimoto, et al.. (2013). A bio‐nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection. Microbiology and Immunology. 57(6). 470–477. 9 indexed citations
4.
Nishioka, Toshihiko, et al.. (2013). Eicosapentaenoic Acid Combined with Optimal Statin Therapy Improves Endothelial Dysfunction in Patients with Coronary Artery Disease. Cardiovascular Drugs and Therapy. 28(1). 53–59. 33 indexed citations
5.
Yoshimoto, Nobuo, Masaya Kurokawa, Masumi Iijima, et al.. (2013). An automated system for high-throughput single cell-based breeding. Scientific Reports. 3(1). 1191–1191. 64 indexed citations
6.
Yoshimoto, Nobuo & Shun’ichi Kuroda. (2013). Single-cell-based breeding: Rational strategy for the establishment of cell lines from a single cell with the most favorable properties. Journal of Bioscience and Bioengineering. 117(4). 394–400. 7 indexed citations
7.
Iijima, Masumi, Nobuo Yoshimoto, Tomoaki Niimi, Andrés D. Maturana, & Shun’ichi Kuroda. (2013). Nanocapsule-based probe for evaluating the orientation of antibodies immobilized on a solid phase. The Analyst. 138(12). 3470–3470. 8 indexed citations
8.
Nakamura, Yoko, Masumi Iijima, Nobuo Yoshimoto, et al.. (2012). The C‐terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1. FEBS Letters. 586(16). 2500–2506. 24 indexed citations
9.
Kuroda, Shun’ichi, Hidenori Matsuo, Nobuo Yoshimoto, et al.. (2012). Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells. International Journal of Nanomedicine. 7. 3341–3341. 16 indexed citations
10.
Iijima, Masumi, Masaharu Somiya, Nobuo Yoshimoto, Tomoaki Niimi, & Shun’ichi Kuroda. (2012). Nano-visualization of oriented-immobilized IgGs on immunosensors by high-speed atomic force microscopy. Scientific Reports. 2(1). 790–790. 35 indexed citations
11.
Yamada, Mitsuo, Joohee Jung, Masumi Iijima, et al.. (2011). Hepatitis B virus envelope L protein-derived bio-nanocapsules: Mechanisms of cellular attachment and entry into human hepatic cells. Journal of Controlled Release. 160(2). 322–329. 21 indexed citations
12.
Maturana, Andrés D., Noritaka Nakagawa, Nobuo Yoshimoto, et al.. (2011). LIM domains regulate protein kinase C activity: A novel molecular function. Cellular Signalling. 23(5). 928–934. 19 indexed citations
13.
Iijima, Masumi, Giman Jung, John G. Quinn, et al.. (2010). Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus protein A for displaying IgGs on immunosensor chips. Biomaterials. 32(6). 1455–1464. 58 indexed citations
14.
15.
Sasaki, Osamu, Toshihiko Nishioka, Toshiyuki Ando, et al.. (2007). PJ-005 Longitudinal Inhomogeneity of Coronary Distensibility in Acute Coronary Syndrome Related Plaques(Acute coronary syndrome, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society). Japanese Circulation Journal-english Edition. 71. 471. 1 indexed citations
16.
Tatematsu, Kenji, Nobuo Yoshimoto, Tomoyoshi Koyanagi, et al.. (2005). Nuclear-Cytoplasmic Shuttling of a RING-IBR Protein RBCK1 and Its Functional Interaction with Nuclear Body Proteins. Journal of Biological Chemistry. 280(24). 22937–22944. 21 indexed citations
17.
Takeda, Hiroshi, et al.. (1999). Nicorandil, a Potassium Channel Opener, Abolished Torsades de Pointes in a Patient with Complete Atrioventricular Block. Pacing and Clinical Electrophysiology. 22(4). 686–688. 12 indexed citations
18.
H, Ito, et al.. (1998). Class IC Antiarrhythmic Drugs, Flecainide and Pilsicainide, Produce ST Segment Elevation Simulating Inferior Myocardial Ischemia. Journal of Cardiovascular Electrophysiology. 9(8). 855–858. 19 indexed citations
19.
Toda, Iku, Akira Nozaki, Kiyoshi Kawakubo, et al.. (1989). Effect of thromboxane A, synthetase inhibitor:Ventricular fibrillation threshold during and after the release of coronary artery occlusion. 21(4). 404–410.
20.
Uchida, Yasumi, Nobuo Yoshimoto, & Satoru Murao. (1977). EFFECTS OF ASPIRIN, INDOMETHACIN AND THE OTHER AGENTS WHICH INHIBIT PROSTAGRANDIN SYNTHESIS ON CYCLICAL REDUCTION IN BLOOD FLOW OF PARTIALLY CONSTRICTED CORONARY ARTERY : IIIrd Auditorium. Japanese Circulation Journal-english Edition. 41(7). 785. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Versteilen Breakdown of academic impact, for papers by Begoña Lavín Breakdown of academic impact, for papers by Juichiro Shimizu Breakdown of academic impact, for papers by Cesare Balduini Breakdown of academic impact, for papers by H Nakazawa Breakdown of academic impact, for papers by S. Nees Breakdown of academic impact, for papers by Bernhard J. Kirschbaum Breakdown of academic impact, for papers by J L Salzmann Breakdown of academic impact, for papers by Carlos Tarín Breakdown of academic impact, for papers by Aiilyan K. Houng
Rankless by CCL
2026